Weaver David A
Department of Statistics, University of South Carolina, Columbia, SC 29208, United States.
Health Aff Sch. 2023 Dec 8;2(1):qxad082. doi: 10.1093/haschl/qxad082. eCollection 2024 Jan.
New data from the Social Security Administration suggest there were 260 000 excess deaths in the United States among current or former disability beneficiaries during the first 22 months of the COVID-19 pandemic. These beneficiaries accounted for 26% of all excess deaths in the United States during this period. The pattern of deaths among disabled beneficiaries corresponds closely to known milestones in the pandemic's history. Disabled beneficiaries in New York, particularly those residing in institutions, had extremely elevated mortality with the onset of the pandemic in the spring of 2020. Across all regions in the United States, mortality among disability beneficiaries increased sharply with the onset of the winter of 2020-2021 and with the emergence of the Delta and Omicron variants in 2021. Elevated mortality was observed for persons with intellectual, mental, and physical impairments. Future public information campaigns about vaccines and other measures may be more successful if they include specific efforts to directly target disability beneficiaries. In addition, clinical trials and other research should consider including disabled persons as specific study groups as the severity of their underlying health impairments is likely comparable to that of persons of advanced age.
美国社会保障管理局的新数据显示,在新冠疫情的前22个月里,美国目前或以前的残疾福利受益人中有26万人死亡人数过多。在此期间,这些受益人占美国所有死亡人数过多情况的26%。残疾受益人中的死亡模式与疫情历史上已知的里程碑密切相关。纽约的残疾受益人,尤其是那些居住在机构中的人,在2020年春季疫情爆发时死亡率极高。在美国所有地区,随着2020 - 2021年冬季的到来以及2021年德尔塔和奥密克戎变种的出现,残疾受益人的死亡率急剧上升。智力、精神和身体有障碍的人死亡率较高。如果未来关于疫苗和其他措施的公共宣传活动包括直接针对残疾受益人的具体努力,可能会更成功。此外,临床试验和其他研究应考虑将残疾人作为特定研究群体纳入,因为他们潜在健康损害的严重程度可能与老年人相当。